Small molecule modulators of protein-protein interactions: selected case studies

Aeluri, Madhu, Chamakuri, Srinivas, Dasari, Bhanudas, Guduru, Shiva Krishna Reddy, Jimmidi, Ravikumar, Jogula, Srinivas, Arya, Prabhat·2014·Chemical Reviews

Cites (525)

Items 201–400 of 525

  1. The Microtubule Stabilizing Agent Laulimalide Does Not Bind in the Taxoid Site, Kills Cells Resistant to Paclitaxel and Epothilones, and May Not Require Its Epoxide Moiety for Activity
    Donald E. Pryor, Aurora O’Brate, Geoffrey M. Bilcer, José Fernando Díaz, Yuefang Wang, Yong Wang, Mikio Kabaki, M. Katherine Jung, José M. Andreu, Arun Kumar Ghosh et al. · 2002 · Biochemistry
  2. Regulation of microtubule stability and mitotic progression by survivin.
    Alessandra Giodini, Marko J. Kallio, Nathan R. Wall · 2002 · PubMed
  3. Chemistry and biology of resorcylic acid lactones
    Nicolas Winssinger, Sofía Barluenga · 2006 · Chemical Communications
  4. Structure of a 14-3-3 Coordinated Hexamer of the Plant Plasma Membrane H+-ATPase by Combining X-Ray Crystallography and Electron Cryomicroscopy
    Ottmann, Christian, Marco, Sergio, Jaspert, Nina, Marcon, Caroline, Schauer, Nicolas, Weyand, Michael, Vandermeeren, Caroline, Duby, Geoffrey, Boutry, Marc, Wittinghofer, Alfred et al. · 2007 · Molecular Cell
  5. NMR Structure and Mutagenesis of the Third Bir Domain of the Inhibitor of Apoptosis Protein XIAP
    Chaohong C. Sun, Mengli Cai, Robert P. Meadows, Nan Xu, Angelo H. Gunasekera, Julia E. Herrmann, Joe C. Wu, Stephen W. Fesik · 2000 · Journal of Biological Chemistry
  6. Development of a Potent Bcl-x L Antagonist Based on α-Helix Mimicry
    Olaf Kutzki, Hyung Soon Park, Justin T. Ernst, Brendan P. Orner, Hang Hubert Yin, Andrew D. Hamilton · 2002 · Journal of the American Chemical Society
  7. Discovery of a Potent Small-Molecule Antagonist of Inhibitor of Apoptosis (IAP) Proteins and Clinical Candidate for the Treatment of Cancer (GDC-0152)
    Flygare, John A., Beresini, Maureen, Budha, Nageshwar, Chan, Helen, Chan, Iris T., Cheeti, Sravanthi, Cohen, Frederick, Deshayes, Kurt, Doerner, Karl, Eckhardt, S. Gail et al. · 2012 · Journal of Medicinal Chemistry
  8. Molecular characterization of the hdm2-p53 interaction 1 1Edited by J. Karn
    Angelika Böttger, Volker Böttger, Carlos Garcı́a-Echeverrı́a, Patrick Chêne, Heinz Kurt Hochkeppel, Wayne R. Sampson, Kiah How Ang, Stephanie F. Howard, Steven M. Picksley, David Philip Lane · 1997 · Journal of Molecular Biology
  9. The conserved N‐terminal BH4 domain of Bcl‐2 homologues is essential for inhibition of apoptosis and interaction with CED‐4
    David C.S. Huang, Jerry M. Adams, Suzanne Cory · 1998 · The EMBO Journal
  10. Microtubule dynamics as a target in oncology
    April L. Risinger, Francis Joseph Giles, Susan L. Mooberry · 2008 · Cancer Treatment Reviews
  11. Caspase-8 Activation and Bid Cleavage Contribute to MCF7 Cellular Execution in a Caspase-3-dependent Manner during Staurosporine-mediated Apoptosis
    Damu Tang, Jill M. Lahti, Vincent J. Kidd · 2000 · Journal of Biological Chemistry
  12. Discovery of Potent Antagonists of the Interaction between Human Double Minute 2 and Tumor Suppressor p53
    Carlos Garcı́a-Echeverrı́a, Patrick Chêne, Marcel J. J. Blommers, Pascal Furet · 2000 · Journal of Medicinal Chemistry
  13. Kinetic stabilization of microtubule dynamic instability in vitro by vinblastine
    Robert J. Toso, Mary Ann Jordan, K Farrell, Brian Matsumoto, Leslie Wilson · 1993 · Biochemistry
  14. Novobiocin: Redesigning a DNA Gyrase Inhibitor for Selective Inhibition of Hsp90
    Joseph A. Burlison, Len Neckers, Andrew B Smith, Anthony Maxwell, Brian S. J. Blagg · 2006 · Journal of the American Chemical Society
  15. Mdm2 Regulates p53 mRNA Translation through Inhibitory Interactions with Ribosomal Protein L26
    Yaara Ofir-Rosenfeld, Kristy Boggs, Dan Michael, Michael B. Kastan, Moshe Oren · 2008 · Molecular Cell
  16. Discovery, characterization and SAR of gambogic acid as a potent apoptosis inducer by a HTS assay
    Han‐Zhong Zhang, Shailaja Kasibhatla, Yan Wang · 2003 · Bioorganic & Medicinal Chemistry
  17. Immunochemical analysis of the interaction of p53 with MDM2;--fine mapping of the MDM2 binding site on p53 using synthetic peptides.
    Steven M. Picksley, B Vojtĕsek, Alison Sparks, David Philip Lane · 1994 · PubMed
  18. Comparison of chemical inhibitors of antiapoptotic Bcl-2-family proteins
    Dayong Zhai, Can Jin, Arnold C. Satterthwait, John C. Reed · 2006 · Cell Death and Differentiation
  19. Caspases, IAPs and Smac/DIABLO: mechanisms from structural biology
    Eric N. Shiozaki, Yigong Shi · 2004 · Trends in Biochemical Sciences
  20. PROPERTIES OF THE PROTEIN SUBUNIT OF CENTRAL-PAIR AND OUTER-DOUBLET MICROTUBULES OF SEA URCHIN FLAGELLA
    Michael L. Shelanski, Edwin William Taylor · 1968 · The Journal of Cell Biology
  21. Interactive exploration of chemical space with Scaffold Hunter
    Stefan Wetzel, Karsten Klein, Steffen Renner, Daniel Rauh, Tudor Ionel Oprea, Petra Mutzel, Herbert Waldmann · 2009 · Nature Chemical Biology
  22. Clinical Development of 17-Allylamino, 17-Demethoxygeldanamycin
    Edward A. Sausville, Joseph E. Tomaszewski, Percy S. Ivy · 2003 · Current Cancer Drug Targets
  23. A Molecular Tweezer for Lysine and Arginine
    Michael Fokkens, Thomas H. Schrader, Frank‐Gerrit Klärner · 2005 · Journal of the American Chemical Society
  24. Inhibition of cyclin-dependent kinases 2 and 4 activities as well as induction of cdk inhibitors p21 and p27 during growth arrest of human breast carcinoma cells by (?)-epigallocatechin-3-gallate
    Yu‐Chih Liang, Shoei‐Yn Lin‐Shiau, Chieh-Fu Chen, Jen‐Kun Lin · 1999 · Journal of Cellular Biochemistry
  25. Quantitation of chemopreventive synergism between (-)-epigallocatechin- 3-gallate and curcumin in normal, premalignant and malignant human oral epithelial cells
    Avi Khafif · 1998 · Carcinogenesis
  26. Melatonin synthesis: 14-3-3-dependent activation and inhibition of arylalkylamine N -acetyltransferase mediated by phosphoserine-205
    Surajit Ganguly, Joan L. Weller, Anthony Ho, Philippe Chemineau, Benoît Malpaux, David C. Klein · 2005 · Proceedings of the National Academy of Sciences
  27. Cryptophycin: a new antimicrotubule agent active against drug-resistant cells.
    C.D. Smith, Xiuguo Zhang, Susan L. Mooberry, Gregory M. L. Patterson, Richard E. Moore · 1994 · PubMed
  28. Microtubule dynamics: taking aim at a moving target
    Leslie Wilson, Mary Ann Jordan · 1995 · Chemistry & Biology
  29. Expression and Genetic Analysis of XIAP-Associated Factor 1 (XAF1) in Cancer Cell Lines
    Wai Gin Fong, Peter Liston, Evica Rajcan‐Separovic, Martine St. Jean, Constance G. Craig, Robert G. Korneluk · 2000 · Genomics
  30. Design, Synthesis, and Characterization of a Potent, Nonpeptide, Cell-Permeable, Bivalent Smac Mimetic That Concurrently Targets Both the BIR2 and BIR3 Domains in XIAP
    Haiying Sun, Zaneta Nikolovska‐Coleska, Jianfeng Lü, Jennifer L. Meagher, Chao‐Yie Yang, Su Qiu, York A. Tomita, Yumi Ueda, Sheng Jiang, Krzysztof Krajewski et al. · 2007 · Journal of the American Chemical Society
  31. A Nucleotide-dependent Molecular Switch Controls ATP Binding at the C-terminal Domain of Hsp90
    Csaba Sőti, Áttila Rácz, Péter Csermely · 2002 · Journal of Biological Chemistry
  32. Microtubule Dynamics and Kinetochore Function in Mitosis
    Timothy John Mitchison · 1988 · Annual Review of Cell Biology
  33. Targeting cell division: Small-molecule inhibitors of FtsZ GTPase perturb cytokinetic ring assembly and induce bacterial lethality
    Danielle Nina Margalit, Laura Romberg, Rebecca B. Mets-Halgrimson, Alan M. Hebert, Timothy John Mitchison, Marc W. Kirschner, Debabrata RayChaudhuri · 2004 · Proceedings of the National Academy of Sciences
  34. Grand Challenge Commentary: Accessing new chemical space for 'undruggable' targets
    Sivaraman Dandapani, Lisa A. Marcaurelle · 2010 · Nature Chemical Biology
  35. Dynamic control of signaling by modular adaptor proteins
    Tony J. Pawson · 2007 · Current Opinion in Cell Biology
  36. Total synthesis of prodigiosin, prodigiosene, and desmethoxyprodigiosin: Diels-Alder reactions of heterocyclic azadienes and development of an effective palladium(II)-promoted 2,2'-bipyrrole coupling procedure
    Dale L. Boger, Mona Patel · 1988 · The Journal of Organic Chemistry
  37. X-Linked Inhibitor of Apoptosis Protein (XIAP) Is a Nonredundant Modulator of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL)- Mediated Apoptosis in Human Cancer Cells
    Cummins, Jordan M., Kohli, Manu, Rago, Carlo, Kinzler, Kenneth W., Vogelstein, Bert, Bunz, Fred · 2004 · Cancer Research
  38. Inhibition of the oncogene product p185erbB-2 in vitro and in vivo by geldanamycin and dihydrogeldanamycin derivatives
    Rodney C. Schnur, Michael L. Corman, Randall J. Gallaschun, Beth A. Cooper, Michael F. Dee, Jonathan L. Doty, M. L. Muzzi, James D. Moyer, C DiOrio · 1995 · Journal of Medicinal Chemistry
  39. Molecular tweezers modulate 14-3-3 protein–protein interactions
    David Bier, Rolf Rose, Kenny Bravo‐Rodriguez, Maria Bartel, Juan Manuel Ramírez‐Anguita, Som Dutt, Constanze Wilch, Frank‐Gerrit Klärner, Elsa Sánchez‐García, Thomas H. Schrader et al. · 2013 · Nature Chemistry
  40. MDM2 inhibits p300-mediated p53 acetylation and activation by forming a ternary complex with the two proteins
    Eric Kobet, Xiaoya Zeng, Yong Zhu, David Keller, Hua Lu · 2000 · Proceedings of the National Academy of Sciences
  41. Antineoplastic agents. 219. Isolation and structure of the cell growth inhibitory constituents from the western Pacific marine sponge Axinella sp
    George R. Pettit, Cherry L. Herald, Michael R. Boyd, John E. Leet, Claude Dufresne, Dennis L. Doubek, Jean M. Schmidt, Ronald L. Cerny, John N. A. Hooper, Klaus C. Rutzler · 1991 · Journal of Medicinal Chemistry
  42. Amino-acid Composition of “Tubulin” constituting Microtubules of Sperm Flagella
    Hideo Mohri · 1968 · Nature
  43. Natural products which interact with tubulin in the vinca domain: Maytansine, rhizoxin, phomopsin a, dolastatins 10 and 15 and halichondrin B
    Ernest Hamel · 1992 · Pharmacology & Therapeutics
  44. Human Ovarian Cancer and Cisplatin Resistance: Possible Role of Inhibitor of Apoptosis Proteins1
    Julang Li, Qiang Feng, Jong‐Min Kim et al. · 2001 · Endocrinology
  45. Structure determination, conformational analysis, chemical stability studies, and antitumor evaluation of the cryptophycins. isolation of 18 new analogs from nostoc sp. strain GSV 224
    Golakoti, Trimurtulu, Ogino, Junichi, Heltzel, Carl E., Le Husebo, Trang, Jensen, Craig M., Larsen, Linda K., Patterson, Gregory M. L., Moore, Richard E., Mooberry, Susan L., Corbett, Thomas H. et al. · 1995 · Journal of the American Chemical Society
  46. 14-3-3 α and δ Are the Phosphorylated Forms of Raf-activating 14-3-3 β and ζ
    Alastair Aitken, Steven A. Howell, David T. Jones · 1995 · Journal of Biological Chemistry
  47. The Synthesis of Prodigiosin
    Henry Rapoport, Kenneth G. Holden · 1962 · Journal of the American Chemical Society
  48. Fusicoccin: a New Wilting Toxin produced by Fusicoccum amygdali Del.
    ALESSANDRO BALLIO, Ernst Boris Chain, Piero De Leo, B. F. ERLANGER, M. MAURI, A. TONOLO · 1964 · Nature
  49. Microtubule Active Agents: Beyond the Taxane Frontier
    Patrick Glyn Morris, Monica Nancy Fornier · 2008 · Clinical Cancer Research
  50. p53 regulation by post-translational modification and nuclear retention in response to diverse stresses
    Gretchen S. Jimenez, Shireen H Khan, Jayne M. Stommel, Geoffrey M. Wahl · 1999 · Oncogene
  51. Bax channel inhibitors prevent mitochondrion-mediated apoptosis and protect neurons in a model of global brain ischemia
    Hetz, Claudio, Vitte, Pierre-Alain, Bombrun, Agnes, Rostovtseva, Tatiana K., Montessuit, Sylvie, Hiver, Agnes, Schwarz, Matthias K., Church, Dennis J., Korsmeyer, Stanley J., Martinou, Jean-Claude et al. · 2005 · Journal of Biological Chemistry
  52. Protein–protein interactions and cancer: small molecules going in for the kill
    Michelle R. Arkin · 2005 · Current Opinion in Chemical Biology
  53. Design, Synthesis, and Biological Activity of a Potent Smac Mimetic That Sensitizes Cancer Cells to Apoptosis by Antagonizing IAPs
    Kerry Zobel, Lan Wang, Eugene E. Varfolomeev, Matthew C. Franklin, Linda O. Elliott, Heidi J.A. Wallweber, David C. Okawa, John A. Flygare, Domagoj Vucic, Wayne J. Fairbrother et al. · 2006 · ACS Chemical Biology
  54. Hsp90 Inhibitors Identified from a Library of Novobiocin Analogues
    Xiao Ming Yu, Gang Shen, Len Neckers, Helen M. Blake, Jeff M. Holzbeierlein, Benjamin B. Cronk, Brian S. J. Blagg · 2005 · Journal of the American Chemical Society
  55. Current strategies for diversity-oriented synthesis
    Sivaraman Dandapani, Lisa A. Marcaurelle · 2010 · Current Opinion in Chemical Biology
  56. Advances in Solution- and Solid-Phase Synthesis toward the Generation of Natural Product-like Libraries
    Jyoti Prokash Nandy, Michael A. Prakesch, Shahriar Khadem · 2009 · Chemical Reviews
  57. Isolation and Structure Elucidation of Chlorofusin, a Novel p53-MDM2 Antagonist from a Fusarium sp.
    Sara J. Duncan, Sabine Grüschow, Dudley Howard Williams, Carole McNicholas, Ravinder Purewal, Michal Hájek, Martin Gerlitz, Steven Martin, Stephen K. Wrigley, Michael Moore · 2001 · Journal of the American Chemical Society
  58. Solution‐Phase Combinatorial Libraries: Modulating Cellular Signaling by Targeting Protein–Protein or Protein–DNA Interactions
    Dale L. Boger, Joel Desharnais, Kevin Capps · 2003 · Angewandte Chemie International Edition
  59. Kinetic suppression of microtubule dynamic instability by griseofulvin: Implications for its possible use in the treatment of cancer
    Dulal Panda, Krishnan Rathinasamy, Manas Kumar Santra, Leslie Wilson · 2005 · Proceedings of the National Academy of Sciences
  60. 1,4-Benzodiazepine-2,5-diones as small molecule antagonists of the HDM2–p53 interaction: discovery and SAR
    Daniel J. Parks, Louis V. LaFrance, Raul R. Calvo, Karen L. Milkiewicz, Varsha Gupta, Jennifer Lattanze, Kannan Ramachandren, Theodore E. Carver, Eugene C. Petrella, Maxwell D. Cummings et al. · 2004 · Bioorganic & Medicinal Chemistry Letters
  61. Direct and selective small-molecule activation of proapoptotic BAX
    Evripidis Gavathiotis, Denis E. Reyna, Joseph A. Bellairs, Elizaveta S. Leshchiner, Loren D. Walensky · 2012 · Nature Chemical Biology
  62. A novel BH3 ligand that selectively targets Mcl-1 reveals that apoptosis can proceed without Mcl-1 degradation
    Erinna F. Lee, Peter E. Czabotar, Mark F. van Delft, Ewa Malgorzata Michalak, Michelle J. Boyle, Simon N. Willis, Hamsa Puthalakath, Philippe Bouillet, Peter M. Colman, David C.S. Huang et al. · 2008 · The Journal of Cell Biology
  63. Total Synthesis of Cryptophycins. Revision of the Structures of Cryptophycins A and C
    Russell Allan Barrow, Thomas K. Hemscheidt, Jian Liang, Seunguk Paik, Richard E. Moore, Marcus A. Tius · 1995 · Journal of the American Chemical Society
  64. The Microtubule Plus-End Proteins EB1 and Dynactin Have Differential Effects on Microtubule Polymerization
    Lee A. Ligon, Spencer S. Shelly, Mariko K. Tokito, Erika L.F. Holzbaur · 2003 · Molecular Biology of the Cell
  65. The Olefin Metathesis Approach to Epothilone A and Its Analogues
    Kyriacos Costa Nicolaou, Yan He, Dionisios Vourloumis · 1997 · Journal of the American Chemical Society
  66. The fusicoccin receptor of plants is a member of the 14‐3‐3 superfamily of eukaryotic regulatory proteins
    Claudia Oecking, Christoph Eckerskorn, Elmar W. Weiler · 1994 · FEBS Letters
  67. Localization of the Vinblastine-binding Site on β-Tubulin
    Sadananda S. Rai, J. Wolff · 1996 · Journal of Biological Chemistry
  68. Structure-Based Design of Novel Inhibitors of the MDM2–p53 Interaction
    Yosup Rew, Daqing Sun, Felix González-López de Turiso, Michael D. Bartberger, Hilary P. Beck, Jude R. Canon, Ada Chen, David T. Chow, Jeffrey Deignan, Brian M. Fox et al. · 2012 · Journal of Medicinal Chemistry
  69. Synthesis and structure-activity relations of bestatin analogs, inhibitors of aminopeptidase B
    RINZO NISHIZAWA, Tetsushi Saino, TOMOHISA TAKITA · 1977 · Journal of Medicinal Chemistry
  70. Macrocyclic ketone analogues of halichondrin B
    Wanjun Zheng, Boris M. Seletsky, Monica H. Palme et al. · 2004 · Bioorganic & Medicinal Chemistry Letters
  71. Network medicine
    Tony J. Pawson, Rune Linding · 2008 · FEBS Letters
  72. Reprieval from execution: the molecular basis of caspase inhibition
    Henning R. Stennicke, Ciara Ryan, Guy S. Salvesen · 2002 · Trends in Biochemical Sciences
  73. Discovery and development of heat shock protein 90 inhibitors
    Tony Taldone, Weilin Sun, Gabriela Chiosis · 2008 · Bioorganic & Medicinal Chemistry
  74. Modulation of Chaperone Function and Cochaperone Interaction by Novobiocin in the C-terminal Domain of Hsp90
    Rudi K. Allan, Danny Mok, Bryan K. Ward, Thomas Ratajczak · 2006 · Journal of Biological Chemistry
  75. Kinetic studies of RNA–protein interactions using surface plasmon resonance
    Phinikoula S. Katsamba · 2002 · Methods
  76. Structure-Based Design of Potent, Conformationally Constrained Smac Mimetics
    Haiying Sun, Zaneta Nikolovska‐Coleska, Chao‐Yie Yang, Liang Xu, Meilan Liu, York A. Tomita, Hongguang Pan, Yoshiko Yoshioka, Krzysztof Krajewski, Peter P. Roller et al. · 2004 · Journal of the American Chemical Society
  77. Identification of Chelerythrine as an Inhibitor of BclXL Function
    Shing Leng Chan, Mei Lee, Kuan Onn Tan, Lay‐Kien Yang, Alex S. Y. Lee, Horst Flotow, Nai Yang Fu, Mark S. Butler, Djaja Doel Soejarto, Antony David Buss et al. · 2003 · Journal of Biological Chemistry
  78. Ixabepilone (Epothilone B Analogue BMS-247550) Is Active in Chemotherapy-Naive Patients With Hormone-Refractory Prostate Cancer: A Southwest Oncology Group Trial S0111
    Maha Hussain, Catherine M. Tangen, Primo N. Lara, Ulka N. Vaishampayan, Daniel Peter Petrylak, Alexander Dimitrios Colevas, Wael Sakr, Elward David Crawford · 2005 · Journal of Clinical Oncology
  79. Targeting protein–protein interactions for cancer therapy
    David C. Fry, Lyubomir T. Vassilev · 2005 · Journal of Molecular Medicine
  80. Chirospecific syntheses of (+)- and (-)-anatoxin a
    John S. Petersen, Gregor Fels, Henry Rapoport · 1984 · Journal of the American Chemical Society
  81. Requirement of Both the Second and Third BIR Domains for the Relief of X-linked Inhibitor of Apoptosis Protein (XIAP)-mediated Caspase Inhibition by Smac
    Huang, Yihua, Rich, Rebecca L., Myszka, David G., Wu, Hao · 2003 · Journal of Biological Chemistry
  82. Synthesis and biological activities of novel 17-aminogeldanamycin derivatives
    Zong‐Qiang Tian, Yaoquan Liu, Dan Zhang, Zhan Wang, Steven D. Dong, Christopher W. Carreras, Yiqing Zhou, Giulio Rastelli, Daniel V. Santi, David C. Myles · 2004 · Bioorganic & Medicinal Chemistry
  83. Molecular Dissection of the Microtubule Depolymerizing Activity of Mitotic Centromere-associated Kinesin
    Todd Maney, Michael Wagenbach, Linda G. Wordeman · 2001 · Journal of Biological Chemistry
  84. Antimitotic and tubulin-interacting properties of vinflunine, a novel fluorinated Vinca alkaloid
    Anna Kruczynski, Jean-Marc M. Barret, Chantal Etiévant · 1998 · Biochemical Pharmacology
  85. In Vivo Photocrosslinking with Unnatural Amino Acid Mutagenesis
    Jason W. Chin, Peter G. Schultz · 2002 · ChemBioChem
  86. Discovery and Optimization of Chromenotriazolopyrimidines as Potent Inhibitors of the Mouse Double Minute 2−Tumor Protein 53 Protein−Protein Interaction
    John G. Allen, Matthew P. Bourbeau, G. Erich Wohlhieter, Michael D. Bartberger, Klaus Michelsen, Randall W. Hungate, Robert C. Gadwood, Rick D. Gaston, Bruce Evans, Larry W. Mann et al. · 2009 · Journal of Medicinal Chemistry
  87. The Halichondrins and E7389
    Katrina L. Jackson, James A. Henderson, Andrew J. Phillips · 2009 · Chemical Reviews
  88. Molecular Clip and Tweezer Introduce New Mechanisms of Enzyme Inhibition
    Peter Talbiersky, Frank Bastkowski, Frank‐Gerrit Klärner · 2008 · Journal of the American Chemical Society
  89. Pochonins A−F, New Antiviral and Antiparasitic Resorcylic Acid Lactones from Pochonia chlamydosporia var. catenulata
    Veronika Hellwig, Anke Mayer‐Bartschmid, Hartwig Müller · 2003 · Journal of Natural Products
  90. A Small-Molecule Inhibitor of Bcl-XL Potentiates the Activity of Cytotoxic Drugs In vitro and In vivo
    Alex R. Shoemaker, Anatol Oleksijew, Joy L. Bauch, Barbara Belli, Tony Borre, Milan Bruncko, Thomas Deckwirth, David J. Frost, Ken Jarvis, Mary K. Joseph et al. · 2006 · Cancer Research
  91. A Novel Application of a Pd(0)-Catalyzed Nucleophilic Substitution Reaction to the Regio- and Stereoselective Synthesis of Lactam Analogues of the Epothilone Natural Products
    R. M. Borzilleri, Xiaoping Zheng, Robert J. Schmidt et al. · 2000 · Journal of the American Chemical Society
  92. Managing taxane toxicities
    Maurie M. Markman · 2003 · Supportive Care in Cancer
  93. Concise Asymmetric Syntheses of Radicicol and Monocillin I
    R. M. Garbaccio, Shawn J. Stachel, Daniel K. Baeschlin · 2001 · Journal of the American Chemical Society
  94. Exploring New Chemical Space by Stereocontrolled Diversity-Oriented Synthesis
    P. Arya, Reni Joseph, Zhonghong Gan, Bojana Rakić · 2005 · Chemistry & Biology
  95. Bioactivity-guided mapping and navigation of chemical space
    Steffen Renner, Willem A. L. van Otterlo, Marta Domínguez, Sabine Möcklinghoff, Bettina Hofmann, Stefan Wetzel, Ansgar Schuffenhauer, Peter Ertl, Tudor Ionel Oprea, Dieter Steinhilber et al. · 2009 · Nature Chemical Biology
  96. Identification and partial characterization of new antigens from simian virus 40-transformed mouse cells
    Chung-Ming Chang, Daniel T. Simmons, Miguel Martı́n · 1979 · Journal of Virology
  97. Organic synthesis toward small-molecule probes and drugs
    Stuart L. Schreiber · 2011 · Proceedings of the National Academy of Sciences
  98. Discovery and Structure−Activity Relationship of Antagonists of B-Cell Lymphoma 2 Family Proteins with Chemopotentiation Activity in Vitro and in Vivo
    Michael D. Wendt, Shen Wang, Aaron R. Kunzer, William J. McClellan, Milan Bruncko, Thorsten K. Oost, Hong Ding, Mary K. Joseph, Haichao Zhang, Paul M. Nimmer et al. · 2006 · Journal of Medicinal Chemistry
  99. Engineering ML-IAP to produce an extraordinarily potent caspase 9 inhibitor: implications for Smac-dependent anti-apoptotic activity of ML-IAP
    Domagoj Vucic, Matthew C. Franklin, Heidi J.A. Wallweber, Kanad DAS, Brendan P. Eckelman, Hwain Shin, Linda O. Elliott, Saloumeh Kadkhodayan, Kurt Deshayes, Guy S. Salvesen et al. · 2004 · Biochemical Journal
  100. Bax Inhibitor-1 Regulates Endoplasmic Reticulum Stress-associated Reactive Oxygen Species and Heme Oxygenase-1 Expression
    Geum‐Hwa Lee, Hyun-Kyung Kim, Soo‐Wan Chae, Do‐Sung Kim, Ki-Chan Ha, Mike Cuddy, Christina L. Kress, John C. Reed, Hyung‐Ryong Kim, Han–Jung Chae · 2007 · Journal of Biological Chemistry
  101. Analysis by Surface Plasmon Resonance of the Influence of Valence on the Ligand Binding Affinity and Kinetics of an Anti-carbohydrate Antibody
    C. Roger MacKenzie, Tomoko Hirama, Su-Jun Deng, David R. Bundle, Saran Adhar Narang, Noel Martin Young · 1996 · Journal of Biological Chemistry
  102. MDM2-ARF complex regulates p53 sumoylation
    Chen, Lihong, Chen, Jiandong · 2003 · Oncogene
  103. The Small Organic Compound HA14-1 Prevents Bcl-2 Interaction with Bax to Sensitize Malignant Glioma Cells to Induction of Cell Death
    Florence Manero, Fabien Gautier, Tristan Gallenne, Nicolas Cauquil, Danielle M. Gree, Pierre‐François Cartron, Olivier Geneste, Rene L. Gree, François M. Vallette, Philippe Paul Juin · 2006 · Cancer Research
  104. Protein–protein interfaces: mimics and inhibitors
    Andrea G. Cochran · 2001 · Current Opinion in Chemical Biology
  105. KF25706, a novel oxime derivative of radicicol, exhibits in vivo antitumor activity via selective depletion of Hsp90 binding signaling molecules.
    Shiro Soga, L M Neckers, T W Schulte, Yukimasa Shiotsu, K Akasaka, H Narumi, Tsutomu Agatsuma, Y. IKUINA, Chikara Murakata, T Tamaoki et al. · 1999 · PubMed
  106. Structure-Based Design, Synthesis, and Evaluation of Conformationally Constrained Mimetics of the Second Mitochondria-Derived Activator of Caspase That Target the X-Linked Inhibitor of Apoptosis Protein/Caspase-9 Interaction Site
    Haiying Sun, Zaneta Nikolovska‐Coleska, Chao‐Yie Yang, Liang Xu, York A. Tomita, Krzysztof Krajewski, Peter P. Roller, Shaomeng Wang · 2004 · Journal of Medicinal Chemistry
  107. Synergistic Effects of Peloruside A and Laulimalide with Taxoid Site Drugs, but Not with Each Other, on Tubulin Assembly
    Ernest Hamel, Billy W. Day, John Holmes Miller, M. Katherine Jung, Peter T. Northcote, Arun Kumar Ghosh, Dennis P. Curran, Mark Cushman, Kyriacos Costa Nicolaou, Ian Paterson et al. · 2006 · Molecular Pharmacology
  108. Gambogic Acid, a Natural Product Inhibitor of Hsp90
    Jason Davenport, Jacob R. Manjarrez, Laura B. Peterson, Brian Krumm, Brian S. J. Blagg, Robert L. Matts · 2011 · Journal of Natural Products
  109. Phase II Clinical Trial of the Epothilone B Analog, Ixabepilone, in Patients With Non–Small-Cell Lung Cancer Whose Tumors Have Failed First-Line Platinum-Based Chemotherapy
    Johan Vansteenkiste, Primo N. Lara, Thierry Le Chevalier et al. · 2007 · Journal of Clinical Oncology
  110. The client protein p53 adopts a molten globule–like state in the presence of Hsp90
    Park, Sung Jean, Borin, Brendan N, Martinez-Yamout, Maria A, Dyson, H Jane · 2011 · Nature Structural & Molecular Biology
  111. The Middle Domain of Hsp90 Acts as a Discriminator between Different Types of Client Proteins
    Hawle, Patricija, Siepmann, Martin, Harst, Anja, Siderius, Marco, Reusch, H. Peter, Obermann, Wolfgang M. J. · 2006 · Molecular and Cellular Biology
  112. Oncogenic re-wiring of cellular signaling pathways
    Tony J. Pawson, Neil E. Warner · 2007 · Oncogene
  113. Synthesis, Proton-Affinity and Anti-Cancer Properties of the Prodigiosin-Group Natural Products
    Richard A. Manderville · 2001 · Anti-Cancer Agents in Medicinal Chemistry
  114. Identification and Structure of Small‐Molecule Stabilizers of 14–3–3 Protein–Protein Interactions
    Rolf Rose, Silke Erdmann, Stefanie Bovens, Alexander Wolf, Micheline Rose, Sven Hennig, Herbert Waldmann, Christian Ottmann · 2010 · Angewandte Chemie International Edition
  115. Development and Characterization of Nonpeptidic Small Molecule Inhibitors of the XIAP/Caspase-3 Interaction
    Tom Y.-H. Wu, Klaus W Wagner, Badry D. Bursulaya, Peter G. Schultz, Quinn L. Deveraux · 2003 · Chemistry & Biology
  116. Small-molecule XIAP inhibitors derepress downstream effector caspases and induce apoptosis of acute myeloid leukemia cells
    Bing Z. Carter, Marcela Gronda, Zhiliang Wang, Kate Welsh, Clemencia Pinilla, Michael Andreeff, Wendy D. Schober, Adel Nefzi, Gregory R. Pond, Imtiaz A. Mawji et al. · 2005 · Blood
  117. Geldanamycin. I. Structure assignment
    KENNETH L. Jr. RINEHART, Kazuya Sasaki, George Slomp · 1970 · Journal of the American Chemical Society
  118. Gossypol induces Bax/Bak‐independent activation of apoptosis and cytochrome c release via a conformational change in Bcl‐2
    Xiaobo Lei, Yingyu Chen, Guanhua Du, Wenyu Yu, Xiaohui Wang, Hong Qu, Bin Xia, Hongping He, Jianhua Mao, Wei‐Xing Zong et al. · 2006 · The FASEB Journal
  119. A Novel Class of Small Molecule Inhibitors of Hsp90
    Fang Yi, Lynne Regan · 2008 · ACS Chemical Biology
  120. A Novel Approach for Characterizing Protein Ligand Complexes: Molecular Basis for Specificity of Small-Molecule Bcl-2 Inhibitors
    Alexey A. Lugovskoy, Alexei Degterev, Amr F. Fahmy, Pei Zhou, John D. Gross, Junying Yuan, Gerhard Wagner · 2002 · Journal of the American Chemical Society
  121. Structural Mimicry of Canonical Conformations in Antibody Hypervariable Loops Using Cyclic Peptides Containing a Heterochiral Diproline Template
    Michel Favre, Kerstin Moehle, Luyong Jiang, Bernhard Pfeiffer, John A. Robinson · 1999 · Journal of the American Chemical Society
  122. Global approaches to protein–protein interactions
    Gerard Drewes, Tewis Bouwmeester · 2003 · Current Opinion in Cell Biology
  123. The Prodigiosins: A New Family of Anticancer Drugs
    Beatriz Montaner, Ricardo Pérez‐Tomás · 2003 · Current Cancer Drug Targets
  124. Phase III Trials of Eribulin Mesylate (E7389) in Extensively Pretreated Patients With Locally Recurrent or Metastatic Breast Cancer
    Chris Twelves, Javier Cortés, Linda T. Vahdat · 2010 · Clinical Breast Cancer
  125. Potent and specific inhibition of p60v-src protein kinase both in vivo and in vitro by radicicol.
    Ho Jeong Kwon, Minoru Yoshida, Yasuhisa Fukui · 1992 · PubMed
  126. Protein–protein interactions in the allosteric regulation of protein kinases
    Patricia Pellicena, John Kuriyan · 2006 · Current Opinion in Structural Biology
  127. Antiproliferative mechanism of action of cryptophycin-52: Kinetic stabilization of microtubule dynamics by high-affinity binding to microtubule ends
    Dulal Panda, Keith F. DeLuca, Daniel C. Williams, Mary Ann Jordan, Leslie Wilson · 1998 · Proceedings of the National Academy of Sciences
  128. A Semisynthetic Fusicoccane Stabilizes a Protein-Protein Interaction and Enhances the Expression of K+ Channels at the Cell Surface
    Anders, Carolin, Higuchi, Yusuke, Koschinsky, Kristin, Bartel, Maria, Schumacher, Benjamin, Thiel, Philipp, Nitta, Hajime, Preisig-Müller, Regina, Schlichthörl, Günter, Renigunta, Vijay et al. · 2013 · Chemistry & Biology
  129. Mechanistic studies of Sansalvamide A-amide: An allosteric modulator of Hsp90
    Vasko, Robert C., Rodriguez, Rodrigo A., Cunningham, Christian N., Ardi, Veronica C., Agard, David A., McAlpine, Shelli R. · 2010 · ACS Medicinal Chemistry Letters
  130. Discovery and structural characterization of a small molecule 14-3-3 protein-protein interaction inhibitor
    Zhao, Jing, Du, Yuhong, Horton, John R., Upadhyay, Anup K., Lou, Bin, Bai, Yan, Zhang, Xing, Du, Lupei, Li, Minyong, Wang, Binghe et al. · 2011 · Proceedings of the National Academy of Sciences
  131. Antagonism of c-IAP and XIAP Proteins Is Required for Efficient Induction of Cell Death by Small-Molecule IAP Antagonists
    Chudi O. Ndubaku, Eugene E. Varfolomeev, Lan Wang, Kerry Zobel, Kevin Lau, Linda O. Elliott, Brigitte Maurer, Anna V. Fedorova, Jasmin N. Dynek, Michael F. T. Koehler et al. · 2009 · ACS Chemical Biology
  132. Induction of apoptosis in tumor cells by siRNA-mediated silencing of the livin/ML-IAP/KIAP gene
    Irena Crnković‐Mertens, Felix Hoppe‐Seyler, Karin Butz · 2003 · Oncogene
  133. C-terminal Recognition by 14-3-3 Proteins for Surface Expression of Membrane Receptors
    Brian Coblitz, Sojin Shikano, Meng Wu, Sandra B. Gabelli, Lisa M. Cockrell, Matt Spieker, Yoshiro Hanyu, Haian Fu, L. Mario Amzel, Min Li · 2005 · Journal of Biological Chemistry
  134. The Interaction of TOGp with Microtubules and Tubulin
    Cynthia S. Spittle, Sophie Charrasse, Christian Larroque · 2000 · Journal of Biological Chemistry
  135. Mechanism of Action of Cryptophycin
    Charles D. Smith, Xinqun Zhang · 1996 · Journal of Biological Chemistry
  136. The three-dimensional solution structure and dynamic properties of the human FADD death domain 1 1Edited by A. Fersht
    Helena Berglund, Dionne Olerenshaw, Andrew Sankar, Matthias Federwisch, Neil Q. McDonald, Paul C. Driscoll · 2000 · Journal of Molecular Biology
  137. An Approach to Epothilones Based on Olefin Metathesis
    Kyriacos Costa Nicolaou, Yun He, Dionisios Vourloumis · 1996 · Angewandte Chemie International Edition in English
  138. Total Synthesis of (−)-Laulimalide
    Paul A. Wender, Sayee G. Hegde, Robert D. Hubbard · 2002 · Journal of the American Chemical Society
  139. Sensitization of Cervical Cancer Cells to Cisplatin by Genistein: The Role of NFB and Akt/mTOR Signaling Pathways
    Kazım Şahin, Mehmet Tuzcu, Neşe Başak · 2012 · Journal of Oncology
  140. Microarray‐Assisted High‐Throughput Identification of a Cell‐Permeable Small‐Molecule Binder of 14‐3‐3 Proteins
    Hao Wu, Jingyan Ge, Shao Qin Yao · 2010 · Angewandte Chemie International Edition
  141. Natural product-like chemical space: search for chemical dissectors of macromolecular interactions
    Ayub Reayi, P. Arya · 2005 · Current Opinion in Chemical Biology
  142. Tubulin Assembly, Taxoid Site Binding, and Cellular Effects of the Microtubule-Stabilizing Agent Dictyostatin
    Charitha Madiraju, Michael Edler, Ernest Hamel, Brianne S. Raccor, Raghavan Balachandran, Guangyu Zhu, Kenneth A. Giuliano, Andreas Vogt, Youseung Shin, Jean‐Hugues Fournier et al. · 2005 · Biochemistry
  143. Inhibitory effects of tea extracts and (−)-epigallocatechin gallate on DNA synthesis and proliferation of hepatoma and erythroleukemia cells
    Michael Anthony Lea, Qin Xiao, Ankur K. Sadhukhan · 1993 · Cancer Letters
  144. The constitution of gambogic acid
    W. David Ollis, M. V. J. RAMSAY, Ian O. Sutherland · 1965 · Tetrahedron
  145. A Structural Rationale for Selective Stabilization of Anti-tumor Interactions of 14-3-3 proteins by Cotylenin A
    Ottmann, Christian, Weyand, Michael, Sassa, Takeshi, Inoue, Takatsugu, Kato, Nobuo, Wittinghofer, Alfred, Oecking, Claudia · 2009 · Journal of Molecular Biology
  146. Radicicol Leads to Selective Depletion of Raf Kinase and Disrupts K-Ras-activated Aberrant Signaling Pathway
    Shiro Soga, Takako Kozawa, Hiroaki Narumi, Shiro Akinaga, Kenji Irie, Kunihiro Matsumoto, Sreenath V. Sharma, Hirofumi Nakano, Tamio Mizukami, Mitsunobu Hara · 1998 · Journal of Biological Chemistry
  147. Enantioselective Synthesis of Epigallocatechin-3-gallate (EGCG), the Active Polyphenol Component from Green Tea
    Lian‐Hai Li, Tak Hang Chan · 2001 · Organic Letters
  148. Hsp90 as a Target for Drug Development
    Subhabrata Chaudhury, Timothy R. Welch, Brian S. J. Blagg · 2006 · ChemMedChem
  149. Reactivation of p53 by a specific MDM2 antagonist (MI-43) leads to p21-mediated cell cycle arrest and selective cell death in colon cancer
    Shangary, Sanjeev, Ding, Ke, Qiu, Su, Nikolovska-Coleska, Zaneta, Bauer, Joshua A., Liu, Meilan, Wang, Guoping, Lu, Yipin, McEachern, Donna, Bernard, Denzil et al. · 2008 · Molecular Cancer Therapeutics
  150. Cascades of Mammalian Caspase Activation in the YeastSaccharomyces cerevisiae
    Jason Kang, Michael D. Schaber, Srinivasa Murty Srinivasula, Emad S. Alnemri, Gerald Litwack, David J. Hall, Mary‐Ann Bjornsti · 1999 · Journal of Biological Chemistry
  151. Improved Procedure for the Solution Phase Preparation of 1,4-Benzodiazepine-2,5-dione Libraries via Armstrong's Convertible Isonitrile and the Ugi Reaction
    Christopher Hulme, John Peng, Sheng-Yuh Tang · 1998 · The Journal of Organic Chemistry
  152. Cell permeable BH3-peptides overcome the cytoprotective effect of Bcl-2 and Bcl-XL
    Helena L.A. Vieira, Patricia Boya, Isabelle Cohen, Chahrazed El Hamel, D. Haouzi, Sabine Druillennec, Anne-Sophie Belzacq, Catherine Brenner, Bernard Pierre Roques, Guido Kroemer · 2002 · Oncogene
  153. Peloruside A Synergizes with Other Microtubule Stabilizing Agents in Cultured Cancer Cell Lines
    Anja Wilmes, Kelly Bargh, Colleen Kelly · 2007 · Molecular Pharmaceutics
  154. Breast Cancer Cells Can Evade Apoptosis-Mediated Selective Killing by a Novel Small Molecule Inhibitor of Bcl-2
    Pedro J. Real, Yeyu Cao, Renxiao Wang, Zaneta Nikolovska‐Coleska, Jaime Sanz‐Ortiz, Shaomeng Wang, José L. Fernández-Luna · 2004 · Cancer Research
  155. Hexylitaconic acid: A new inhibitor of p53–HDM2 interaction isolated from a marine-derived fungus, Arthrinium sp.
    Sachiko Tsukamoto, Takushi Yoshida, Hidetaka Hosono, Tomihisa Ohta, Hideyoshi Yokosawa · 2005 · Bioorganic & Medicinal Chemistry Letters
  156. Dissecting Fas signaling with an altered-specificity death-domain mutant: Requirement of FADD binding for apoptosis but not Jun N-terminal kinase activation
    Howard Y. Chang, Xiaolu Yang, David Baltimore · 1999 · Proceedings of the National Academy of Sciences
  157. Biological properties of Vincaleukoblastine, an alkaloid in Vinca rosea Linn, with reference to its antitumor action.
    James H. Cutts, C. T. Beer, ROBERT L. NOBLE · 1960 · PubMed
  158. Rational Design of Diflunisal Analogues with Reduced Affinity for Human Serum Albumin
    Hongyuan Mao, Philip J. Hajduk, Richard Craig, Randy Bell, Tony Borre, Stephen W. Fesik · 2001 · Journal of the American Chemical Society
  159. Laulimalide and Paclitaxel: A Comparison of Their Effects on Tubulin Assembly and Their Synergistic Action When Present Simultaneously
    Eric J. Gapud, Ruoli Bai, Arun Kumar Ghosh, Ernest Hamel · 2004 · Molecular Pharmacology
  160. Synthesis and Biological Evaluation of a New Class of Geldanamycin Derivatives as Potent Inhibitors of Hsp90
    Jean‐Yves Le Brazidec, Adeela Kamal, David J. Busch, Lia Thao, Lin Zhang, Gregg A. Timony, Roy Grecko, Katy Trent, Rachel E. Lough, Tim Salazar et al. · 2004 · Journal of Medicinal Chemistry
  161. The constitution of monorden, an antibiotic with tranquilising action
    Frank McCapra, A. Ian Scott, P. Delmotte, J. Delmotte-Plaquée, Norman S. Bhacca · 1964 · Tetrahedron Letters
  162. Synthesis of a 2,3‘;6‘,3‘ ‘-Terpyridine Scaffold as an α-Helix Mimetic
    Jessica Michaud Davis, Anh Truong, Andrew D. Hamilton · 2005 · Organic Letters
  163. Chrysanthemic acid. V. Thermal and photo [3,3]sigmatropic rearrangements in the cis-2,2-dimethyl-3-isobutenylcyclopropyl isocyanate-3,6-dihydro-3,3,6,6-tetramethyl-2H-azepin-2-one system
    Tadashi Sasaki, Shoji Eguchi, Masatomi Ohno · 1970 · Journal of the American Chemical Society
  164. Design and synthesis of Hsp90 inhibitors: Exploring the SAR of Sansalvamide A derivatives
    Robert P. Sellers, Leslie D. Alexander, Victoria A. Johnson, Chun-Chieh Lin, Jeremiah H. Savage, Ricardo Corral, Jason A. Moss, Tim S. Slugocki, Erinprit K. Singh, Melinda R. Davis et al. · 2010 · Bioorganic & Medicinal Chemistry
  165. Drug resistance associated with loss of p53 involves extensive alterations in microtubule composition and dynamics
    Carlos María Galmarini, Kathy Kamath, A Vanier-Viornery · 2003 · British Journal of Cancer
  166. Total Synthesis of (+)-Geldanamycin and (−)-o-Quinogeldanamycin: Asymmetric Glycolate Aldol Reactions and Biological Evaluation
    Merritt B. Andrus, Erik L. Meredith, Erik J. Hicken · 2003 · The Journal of Organic Chemistry
  167. 3-(5-chloro-2,4-dihydroxyphenyl)-Pyrazole-4-carboxamides as inhibitors of the Hsp90 molecular chaperone
    Paul A. Brough, Xavier Barril, Mandy Beswick · 2005 · Bioorganic & Medicinal Chemistry Letters
  168. Dynamic Interaction of Hsp90 with Its Client Protein p53
    Sung Jean Park, Milka Kostić, H. Jane Dyson · 2011 · Journal of Molecular Biology
  169. Biophysical Characterization of Recombinant Human Bcl-2 and Its Interactions with an Inhibitory Ligand, Antimycin A
    Kristine M. Kim, Chris D. Giedt, Gorka Basáñez · 2001 · Biochemistry
  170. Monomer Arrangement in HSP90 Dimer as Determined by Decoration with N and C-Terminal Region Specific Antibodies
    Mikako Maruya, Masazumi Sameshima, Takayuki Nemoto, Ichiro Yahara · 1999 · Journal of Molecular Biology
  171. New Syntheses of E7389 C14−C35 and Halichondrin C14−C38 Building Blocks: Double-Inversion Approach
    Dae‐Shik Kim, Cheng‐Guo Dong, Joseph T. Kim · 2009 · Journal of the American Chemical Society
  172. Structure-based discovery of a new class of Hsp90 inhibitors
    Xavier Barril, Paul A. Brough, Martin Drysdale · 2005 · Bioorganic & Medicinal Chemistry Letters
  173. Identification of the first non-peptidic small molecule inhibitor of the c-Abl/14-3-3 protein–protein interactions able to drive sensitive and Imatinib-resistant leukemia cells to apoptosis
    Valentina Corradi, Manuela Mancini, Fabrizio Manetti, Sara Petta, Maria Alessandra Santucci, Maurizio Botta · 2010 · Bioorganic & Medicinal Chemistry Letters
  174. In vitro and in vivo anticancer activities of synthetic (-)-laulimalide, a marine natural product microtubule stabilizing agent.
    Junke Liu, Murray J. Towle, Hongsheng Cheng, Philip L. Saxton, Cathy Reardon, Jiayi Wu, Erin A. Murphy, Galina Kuznetsov, Charles William Johannes, Martin R Tremblay et al. · 2007 · PubMed
  175. NMR structure of a complex between MDM2 and a small molecule inhibitor
    David C. Fry, S. Donald Emerson, Stefan Palme, Binh Thanh Vu, Chao‐Min Liu, Frank Podlaski · 2004 · Journal of Biomolecular NMR
  176. Clinical Development of Ixabepilone and Other Epothilones in Patients with Advanced Solid Tumors
    Edgardo Rivera, Joyce Lee, Angela M. Davies · 2008 · The Oncologist
  177. Rapid treadmilling of brain microtubules free of microtubule-associated proteins in vitro and its suppression by tau
    Dulal Panda, Herbert P. Miller, Leslie Wilson · 1999 · Proceedings of the National Academy of Sciences
  178. Three-dimensional structures of proteins involved in programmed cell death
    Heng Liang, Stephen W. Fesik · 1997 · Journal of Molecular Biology
  179. The Solid State, Solution and Tubulin-Bound Conformations of Agents that Promote Microtubule Stabilization
    Jesús Jiménez‐Barbero, Francisco Amat‐Guerri, James P. Snyder · 2005 · Anti-Cancer Agents in Medicinal Chemistry
  180. The central valine concept provides an entry in a new class of non peptide inhibitors of the p53–MDM2 interaction
    Pascal Furet, Patrick Chêne, Alain De Pover, Therese‐Marie Stachyra, Joanna Hergovich Lisztwan, Joerg A. Kallen, Keiichi Masuya · 2012 · Bioorganic & Medicinal Chemistry Letters
  181. Hoiamide D, a marine cyanobacteria-derived inhibitor of p53/MDM2 interaction
    Karla L. Malloy, Hyukjae Choi, Catherine Fiorilla, Fred A. Valeriote, Teatulohi K. Matainaho, William H. Gerwick · 2011 · Bioorganic & Medicinal Chemistry Letters
  182. Characterization of the interaction of cryptophycin 1 with tubulin: binding in the Vinca domain, competitive inhibition of dolastatin 10 binding, and an unusual aggregation reaction.
    R Bai, R E Schwartz, John A. Kepler, G R Pettit, Ernest Hamel · 1996 · PubMed
  183. Quinazoline Sulfonamides as Dual Binders of the Proteins B-Cell Lymphoma 2 and B-Cell Lymphoma Extra Long with Potent Proapoptotic Cell-Based Activity
    Brad E. Sleebs, Peter E. Czabotar, Wayne J. Fairbrother, Walter Douglas Fairlie, John A. Flygare, David C.S. Huang, Wilhelmus J. A. Kersten, Michael F. T. Koehler, Guillaume Lessène, Kym N. Lowes et al. · 2011 · Journal of Medicinal Chemistry
  184. Total Synthesis of the Hsp90 Inhibitor Geldanamycin
    Hua‐Li Qin, James S. Panek · 2008 · Organic Letters
  185. Syntheses of C-3-Modified Sialylglycosides as Selective Inhibitors of Influenza Hemagglutinin and Neuraminidase
    Xue‐Long Sun, Yoshimi Kanie, Chao-tan Guo, Osamu Kanie, Yasuo Suzuki, Chi‐Huey Wong · 2000 · European Journal of Organic Chemistry
  186. New Syntheses of E7389 C14−C35 and Halichondrin C14−C38 Building Blocks: Reductive Cyclization and Oxy-Michael Cyclization Approaches
    Cheng‐Guo Dong, James A. Henderson, Yosuke Kaburagi · 2009 · Journal of the American Chemical Society
  187. Targeting FtsZ for antibacterial therapy: a promising avenue
    Sonia Kapoor, Dulal Panda · 2009 · Expert Opinion on Therapeutic Targets
  188. The Bound Conformation of Microtubule‐Stabilizing Agents: NMR Insights into the Bioactive 3D Structure of Discodermolide and Dictyostatin
    Ángeles Canales, Ruth Matesanz, Nicola M. Gardner, José M. Andreu, Ian Paterson, José Fernando Díaz, Jesús Jiménez‐Barbero · 2008 · Chemistry - A European Journal
  189. Synthesis of (+)-antimycin A3. Use of the oxazole ring in protecting and activating functions
    Harry H. Wasserman, Ronald J. Gambale · 1985 · Journal of the American Chemical Society
  190. Differential effects of active isomers, segments, and analogs of dolastatin 10 on ligand interactions with tubulin
    Ruoli Bai, Mary Carmen Roach, Srirangam K. Jayaram, Jozef Barkoczy, George R. Pettit, Richard F. Ludueña, Ernest Hamel · 1993 · Biochemical Pharmacology
  191. Radester, a Novel Inhibitor of the Hsp90 Protein Folding Machinery
    Gang Shen, Brian S. J. Blagg · 2005 · Organic Letters
  192. Terephthalamide derivatives as mimetics of the helical region of Bak peptide target Bcl-xL protein
    Hang Hubert Yin, Andrew D. Hamilton · 2004 · Bioorganic & Medicinal Chemistry Letters
  193. Modular Asymmetric Synthesis of Pochonin C
    Sofía Barluenga, Pilar López, Émilie Moulin · 2004 · Angewandte Chemie International Edition
  194. Structure of herbimycin A new ansamycin antibiotic
    Satoshi Ōmura, Akira Nakagawa, NORIAKI SADAKANE · 1979 · Tetrahedron Letters
  195. Terphenyl‐Based Helical Mimetics That Disrupt the p53/HDM2 Interaction
    Hang Hubert Yin, Gui‐in Lee, Hyung Soon Park, Gregory A. Payne, Johanna M. Rodriguez, Saı̈d M. Sebti, Andrew D. Hamilton · 2005 · Angewandte Chemie
  196. Design, Synthesis, and Evaluation of a Radicicol and Geldanamycin Chimera, Radamide
    Randell C. Clevenger, Brian S. J. Blagg · 2004 · Organic Letters
  197. Inhibition of Hsp90 with Synthetic Macrolactones: Synthesis and Structural and Biological Evaluation of Ring and Conformational Analogs of Radicicol
    Nicolas Proisy, Swee Y. Sharp, Kathy J. Boxall, Stephen Connelly, Stephen Mark Roe, Chrisostomos Prodromou, Alexandra M. Z. Slawin, Laurence H. Pearl, Paul Workman, Christopher J. Moody · 2006 · Chemistry & Biology
  198. Identification of Inhibitors for MDM2 Ubiquitin Ligase Activity from Natural Product Extracts by a Novel High-Throughput Electrochemiluminescent Screen
    Christy A. Sasiela, David Stewart, Jirouta Kitagaki et al. · 2008 · SLAS DISCOVERY
  199. Solution‐ and Solid‐Phase Synthesis of Radicicol (Monorden) and Pochonin C
    Sofía Barluenga, Émilie Moulin, Pilar López · 2005 · Chemistry - A European Journal
  200. Rigid Dipeptide Mimetics: Efficient Synthesis of Enantiopure Indolizidinone Amino Acids
    Henry‐Georges Lombart, William D. Lubell · 1996 · The Journal of Organic Chemistry